CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP, President US acquired 12,733 shares (option exercise)
- 4 Shares withheld for taxes SVP and CFO gave up 5,317 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,121 shares (to pay taxes)
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 4 Option exercise EVP, President US acquired 47,767 shares (option exercise)
- 4 Shares withheld for taxes SVP and CFO gave up 25,379 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 24,433 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,876 shares (to pay taxes)
- 4 Open-market buy Director bought 12,000 shares at an average $3.25 ($38,999)
Page 17 of 77 · 1,527 filings